← Back to Search

Behavioral Intervention

eMotion for Emotional Well-being

N/A
Recruiting
Led By Kelly L Wierenga, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Has at least mild symptoms of depression (determined by Patient Health Questionnaire-8 [PHQ-8] scores of 5 or greater) and/or at least mild symptoms of anxiety (determined by the General Anxiety Disorder [GAD-7] scores of 5 or greater).
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test an intervention called eMotion that helps women from diverse backgrounds with emotion regulation skills. The intervention was revised to better suit the needs of these women who are more affected by social determin

Who is the study for?
This trial is for women living independently with mild symptoms of depression or anxiety, as measured by specific questionnaires. They must have experienced their first major cardiac event. The study aims to help those particularly affected by social factors that influence health recovery.
What is being tested?
The eMotion intervention is being tested for its relevance and effectiveness in helping women from diverse backgrounds manage emotions after a cardiovascular event. It's based on evidence-based emotion regulation skills tailored to meet unique needs.
What are the potential side effects?
Since eMotion is an emotion regulation training program rather than a drug, it may not have typical medical side effects but could potentially cause emotional discomfort or distress during the learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have mild depression or anxiety based on PHQ-8 or GAD-7 scores.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Distress-Depression and Anxiety Stress Scale
Secondary study objectives
Physical Activity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: eMotion InterventionExperimental Treatment1 Intervention
This is a single-group study assessing participation satisfaction with the 10-week eMotion intervention. The eMotion intervention is based on feasibility testing of the successful in-person program with critical refinement to improve accessibility. eMotion has undergone subsequent content validity testing with intervention development, self-management, cardiovascular health, and health information technology delivery experts. eMotion teaches a carefully selected repertoire of emotion regulation strategies well suited for adults following a first cardiac event.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eMotion
2016
N/A
~110

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
1,034 Previous Clinical Trials
1,118,917 Total Patients Enrolled
1 Trials studying Emotions
40 Patients Enrolled for Emotions
Kelly L Wierenga, PhDPrincipal InvestigatorIndiana University School of Medicine
1 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Emotions
40 Patients Enrolled for Emotions
~18 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top